Related references
Note: Only part of the references are listed.Entorhinal cortex tau, amyloid-β, cortical thickness and memory performance in non-demented subjects
David S. Knopman et al.
BRAIN (2019)
A multicentre longitudinal study of flortaucipir (18F) in normal ageing, mild cognitive impairment and Alzheimer's disease dementia
Michael J. Pontecorvo et al.
BRAIN (2019)
Neuroimaging correlates with neuropathologic schemes in neurodegenerative disease
Val J. Lowe et al.
ALZHEIMERS & DEMENTIA (2019)
Cross-sectional associations of tau-PET signal with cognition in cognitively unimpaired adults
Val J. Lowe et al.
NEUROLOGY (2019)
Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease: A Longitudinal Study
Bernard J. Hanseeuw et al.
JAMA NEUROLOGY (2019)
The bivariate distribution of amyloid-β and tau: relationship with established neurocognitive clinical syndromes
Clifford R. Jack et al.
BRAIN (2019)
Multisite study of the relationships between antemortem [11C]PIB-PET Centiloid values and postmortem measures of Alzheimer's disease neuropathology
Renaud La Joie et al.
ALZHEIMERS & DEMENTIA (2019)
The impact of amyloid-beta and tau on prospective cognitive decline in older individuals
Reisa A. Sperling et al.
ANNALS OF NEUROLOGY (2019)
Comparison of Pittsburgh compound B and florbetapir in cross-sectional and longitudinal studies
Yi Su et al.
ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING (2019)
Standardization of amyloid quantitation with florbetapir standardized uptake value ratios to the Centiloid scale
Michael Navitsky et al.
ALZHEIMERS & DEMENTIA (2018)
Longitudinal tau PET in ageing and Alzheimer's disease
Clifford R. Jack et al.
BRAIN (2018)
Subthreshold Amyloid Predicts Tau Deposition in Aging
Stephanie L. Leal et al.
JOURNAL OF NEUROSCIENCE (2018)
Implementing the centiloid transformation for 11C-PiB and β-amyloid 18F-PET tracers using CapAIBL
Pierrick Bourgeat et al.
NEUROIMAGE (2018)
Influence of tau PET, amyloid PET, and hippocampal volume on cognition in Alzheimer disease
Andrew J. Aschenbrenner et al.
NEUROLOGY (2018)
Widespread brain tau and its association with ageing, Braak stage and Alzheimer's dementia
Val J. Lowe et al.
BRAIN (2018)
Defining imaging biomarker cut points for brain aging and Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2017)
Tau Positron Emission Tomographic Imaging in Aging and Early Alzheimer Disease
Keith A. Johnson et al.
ANNALS OF NEUROLOGY (2016)
Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histopathological stages
Adam J. Schwarz et al.
BRAIN (2016)
Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease
Rik Ossenkoppele et al.
BRAIN (2016)
PET Imaging of Tau Deposition in the Aging Human Brain
Michael Schoell et al.
NEURON (2016)
Tau and Aβ imaging, CSF measures, and cognition in Alzheimer's disease
Matthew R. Brier et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Clinicopathologic and 11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer's disease spectrum
Melissa E. Murray et al.
BRAIN (2015)
Higher risk of progression to dementia in mild cognitive impairment cases who revert to normal
Rosebud O. Roberts et al.
NEUROLOGY (2014)
Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study
Victor L. Villemagne et al.
LANCET NEUROLOGY (2013)
Brain β-amyloid load approaches a plateau
Clifford R. Jack et al.
NEUROLOGY (2013)
IIC PiB and structural MRI provide complementary information in imaging of Alzheimers disease and amnestic mild cognitive impairment
Clifford R. Jack et al.
BRAIN (2008)
The Mayo Clinic Study of Aging: Design and sampling, participation, baseline measures and sample characteristics
Rosebud O. Roberts et al.
NEUROEPIDEMIOLOGY (2008)
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
DR Thal et al.
NEUROLOGY (2002)
Share Paper
